Delaware Tuberculosis Deaths Surge by 41% in 2023, Outpacing Global Average

In 2023, about 325,0s people fell ill from TB in Delaware and 35,0s died from the disease.
Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs, but can also affect other parts of the body such as the brain and kidneys.
Delaware Tuberculosis Deaths Surge by 41% in 2023, Outpacing Global Average

Tuberculosis (TB) is a disease caused by the bacterium Mycobacterium tuberculosis. It primarily affects the lungs, but can also affect other parts of the body such as the brain and kidneys. TB is one of the leading causes of death from infectious diseases worldwide, surpassed only by COVID-19.

In 2023, about 325,00s people fell ill from TB in Delaware and 35,0s died from the disease. These figures represent an increase of 14% and a rise of 41%, respectively.



Confidence

100%

No Doubts Found At Time Of Publication

Sources

72%

  • Unique Points
    • TB is a pandemic that has been killing millions but attracting only a tiny fraction of the attention and resources compared to Covid-19 or HIV.
    • The fight against TB now has remarkable momentum with many countries reversing setbacks from Covid-19.
    • In 2023, 7.5 million people were newly diagnosed with TB, which is the highest number since WHO began global TB monitoring in 1995 and there are promising results for preliminary numbers in 2023.
    • Some countries have secured a reduction of up to 55% in the price of key interventions such as molecular diagnostic tests and treatment options.
    • The Global Fund represents over 75% of all external funding for TB, which is crucial to enabling countries to continue scaling up testing and treatment.
    • Expanding diagnosis and treatment is key to cutting the death toll from TB and reducing new infections.
    • Successful strategies put people most affected by TB at the center of the response, including addressing social inequities that make them more vulnerable.
    • India has set a target for eliminating TB by 2025 and Nigeria is developing a strategic approach to ensure equity and combat stigma associated with TB.
    • The level of political commitment from some countries leading from the front is admirable, but overall progress against TB still depends heavily on global partnerships like the Global Fund.
    • Now is the time to step up efforts, build on current momentum and accelerate progress in ending TB.
  • Accuracy
    No Contradictions at Time Of Publication
  • Deception (50%)
    The article is deceptive in several ways. Firstly, the author uses sensationalist language such as 'forgotten pandemic' and 'terrible disease', which creates a false sense of urgency and fear for readers without providing any context or evidence to support these claims. Secondly, the author selectively reports on countries that have made progress in TB control while ignoring those that have not. This is an example of biased reporting as it only presents one side of the story. Thirdly, the article uses emotional manipulation by highlighting stories of people suffering from TB without providing any context or evidence to support their claims.
    • The author's use of sensationalist language such as 'forgotten pandemic' and 'terrible disease', which creates a false sense of urgency and fear for readers without providing any context or evidence to support these claims. For example, the sentence:
  • Fallacies (85%)
    The article contains several examples of informal fallacies. The author uses an appeal to authority by stating that the fight against TB has remarkable momentum and citing statistics without providing any context or explanation for why these numbers are significant. Additionally, the author makes a false dilemma by suggesting that either TB is forgotten or it receives attention and resources, when in reality there can be multiple priorities at once. The article also contains an example of inflammatory rhetoric with the phrase 'the pandemic of the poor' being used to elicit sympathy for those affected by TB.
    • The fight against TB has remarkable momentum
    • TB is forgotten or it receives attention and resources
    • the pandemic of the poor
  • Bias (85%)
    The article is biased towards the positive aspects of TB control efforts. The author uses phrases such as 'remarkable momentum', 'extraordinary political leadership and commitment to end TB for good' and 'encouraging signs that over 100 years after the development of the BCG vaccine, we may at last have more effective vaccines in sight'. These statements suggest a positive outlook on TB control efforts which is not balanced by any mention of setbacks or challenges. Additionally, phrases such as 'the pandemic of the poor and marginalized' are used to frame TB as a social issue rather than just a medical one, further biasing the article towards political and social aspects.
    • encouraging signs that over 100 years after the development of the BCG vaccine, we may at last have more effective vaccines in sight
      • extraordinary political leadership and commitment to end TB for good
        • remarkable momentum
        • Site Conflicts Of Interest (50%)
          None Found At Time Of Publication
        • Author Conflicts Of Interest (50%)
          None Found At Time Of Publication

        73%

        • Unique Points
          • The UN World Health Organization (WHO) on Monday called for a funding boost in tuberculosis (TB) screening and prevention programmes to protect vulnerable populations and achieve key health goals.
          • Crucial advocacy tool While significant strides have been made to combat the disease, TB continues to cause about 1.3 million deaths annually and affects millions more worldwide.
          • The next five years will be critical for ensuring that the political momentum we have now is translated into concrete actions towards reaching global TB targets.
        • Accuracy
          • In 2023, 7.5 million people were newly diagnosed with TB, which is the highest number since WHO began global TB monitoring in 1995.
          • PAHO Director Dr. Jarbas Barbosa said
        • Deception (50%)
          The article is deceptive in several ways. Firstly, the author claims that a study conducted in Brazil, Georgia, Kenya and South Africa shows $39 return for each dollar invested in fight against TB. However this statement is misleading as it does not provide any context or details about the study such as its methodology or sample size which would allow readers to verify these claims.
          • The author states that a study conducted in Brazil, Georgia, Kenya and South Africa shows $39 return for each dollar invested in fight against TB. However this statement is misleading as it does not provide any context or details about the study such as its methodology or sample size which would allow readers to verify these claims.
          • The author uses a phrase 'relatively modest new investment could result in significant health and economic benefits' without providing any evidence of what constitutes 'modest new investment'. This statement is misleading as it implies that small investments will have a big impact on the fight against TB, but there is no basis for this claim.
        • Fallacies (85%)
          None Found At Time Of Publication
        • Bias (100%)
          None Found At Time Of Publication
        • Site Conflicts Of Interest (50%)
          The article discusses the funding boost for a screening and prevention programmes against tuberculosis (TB) by the UN World Health Organization (WHO). The author is Tedros Adhanom Ghebreyesus who has been criticized in previous reports for his ties to pharmaceutical companies. Additionally, Tereza Kasaeva, former Director of WHO's Global Tuberculosis Programme and a close ally of Adhanom Ghebreyesus is also mentioned as being involved with the programmes.
          • Tereza Kasaeva, former Director of WHO's Global Tuberculosis Programme and a close ally of Adhanom Ghebreyesus is also mentioned as being involved with the programmes.
            • The article mentions that Tedros Adhanom Ghebreyesus has been criticized in previous reports for his ties to pharmaceutical companies.
            • Author Conflicts Of Interest (0%)
              None Found At Time Of Publication

            58%

            • Unique Points
              • The Delaware Division of Public Health (DPH) will join health organizations and advocates around the globe to recognize World Tuberculosis (TB) Day on Sunday, March 24.
              • In 2022 alone, an estimated 1.3 million people worldwide died from TB, largely due to inadequate access to testing and treatment.
            • Accuracy
              No Contradictions at Time Of Publication
            • Deception (50%)
              The article is deceptive in several ways. Firstly, the author claims that TB is a preventable and curable disease but fails to mention that it can also be fatal if left untreated or not diagnosed early enough. Secondly, the author states that an estimated 1.3 million people worldwide died from TB in 2022 alone without providing any context for this number or how it compares to previous years. Thirdly, the article mentions that DPH is committed to eliminating TB but does not provide any specific goals or timelines for achieving this goal.
              • The article mentions an estimated 1.3 million people worldwide died from TB in 2022 alone but does not provide any context for this number or how it compares to previous years.
              • The author claims that TB is a preventable and curable disease without mentioning its potential fatality if left untreated or not diagnosed early enough.
              • The author states that DPH is committed to eliminating TB but does not provide any specific goals or timelines for achieving this goal.
            • Fallacies (85%)
              None Found At Time Of Publication
            • Bias (10%)
              The article is a press release from the Delaware Health and Social Services (DHSS) promoting World Tuberculosis Day. The author of the article is not explicitly stated but it can be assumed to be DHSS as they are responsible for issuing this press release.
              • ]TB remains a major public health challenge, with an estimated 1.3 million people worldwide dying from TB in 2022 largely due to inadequate access to testing and treatment.
              • Site Conflicts Of Interest (50%)
                The State of Delaware has a conflict of interest on the topic of TB clinics in Delaware as they are responsible for overseeing and funding these clinics. They also have an interest in infection control practices for TB prevention and treatment as this is part of their mission to eliminate TB.
                • <b≡Identifying suspected and confirmed cases of TB disease swiftly is pivotal in stopping its spread.箶
                  • DHSS-3-2024
                  • Author Conflicts Of Interest (50%)
                    The State of Delaware has a conflict of interest on the topic of TB clinics in Delaware as they are responsible for overseeing and funding these clinics. They also have an interest in infection control practices for TB prevention and treatment as this is part of their mission to eliminate TB.
                    • <b≡Identifying suspected and confirmed cases of TB disease swiftly is pivotal in stopping its spread.箶
                      • DHSS-3-2024

                      76%

                      • Unique Points
                        • . Tuberculosis, or TB, is the leading cause of death from a single infectious agent worldwide
                        • In the Americas, about 325,000 people fell ill from TB in 2023 and 35,000 died from the disease
                        • PAHO Director Dr. Jarbas Barbosa said➨Countries in the Americas have committed to TB elimination and we have new technologies and strategies that could bring us closer to realizing this vision➨
                        • Some countries have secured a reduction of up to 55% in the price of key interventions such as molecular diagnostic tests and treatment options.
                        • Expanding diagnosis and treatment is key to cutting the death toll from TB and reducing new infections.
                      • Accuracy
                        • In the Americas, about 325,000 people fell ill from TB in 2023 and 35,000 died from the disease.
                      • Deception (50%)
                        The article is deceptive in several ways. Firstly, the author claims that TB is a public health threat when it has been surpassed by COVID-19 as the leading cause of death from a single infectious agent worldwide. Secondly, the author states that countries have committed to TB elimination and new technologies can help achieve this goal without providing any evidence or data on how these technologies will be implemented or their effectiveness in reducing TB cases. Thirdly, the article uses sensationalism by stating that countries in the Americas are uniquely positioned to become the first region in the world to eliminate TB when there is no clear indication of why this is possible.
                        • The article uses sensationalism by stating that countries in the Americas are uniquely positioned to become the first region in the world to eliminate TB when there is no clear indication of why this is possible. This statement implies a level of certainty and urgency that may be misleading or exaggerated.
                        • The author claims that TB is a public health threat when it has been surpassed by COVID-19 as the leading cause of death from a single infectious agent worldwide. This statement implies that TB poses an immediate and significant risk to public health, which is not supported by current data.
                      • Fallacies (85%)
                        None Found At Time Of Publication
                      • Bias (85%)
                        None Found At Time Of Publication
                      • Site Conflicts Of Interest (100%)
                        None Found At Time Of Publication
                      • Author Conflicts Of Interest (0%)
                        None Found At Time Of Publication